Methods for diagnosing onychomycosis: a comparative study and review of the literature.

OBJECTIVE To identify the sensitivity of several readily available diagnostic tests for onychomycosis. DESIGN Cross-sectional study. SETTING Dermatology and podiatry departments at a teaching hospital. PATIENTS Sixty-three adult men and women with a clinical examination highly suggestive of onychomycosis. MAIN OUTCOME MEASURES Sensitivity of each test and of several test combinations. RESULTS Nail samples underwent 6 diagnostic tests. Routine histopathologic examination with periodic acid-Schiff stain (PAS) (PATHPAS) was 85% sensitive. Sensitivities for potassium hydroxide dissolution and centrifugation combined with PAS, fluorescent brightener, or chlorazol black E were 57%, 53%, and 53%, respectively. Culture on Sabouraud agar withchloramphenicol and cycloheximide (Mycosel agar) was 32% sensitive; on Littman-oxgall agar, 23% sensitive. The most sensitive combination of tests, both culture methods plus PATHPAS, was 94% sensitive (not statistically different from the sensitivity of PATHPAS alone [P = .26]). CONCLUSIONS When onychomycosis is suspected clinically, PATHPAS of the nail is the single most sensitive of the diagnostic tests we evaluated. Because it is quickly performed and relatively operator independent, PATHPAS is practical for clinical and research purposes. Further study is needed to determine if sensitivity may be enhanced by combining PATHPAS with cultures obtained by several collection methods (clipping, curettage, and shaving). Such combinations may serve as sensitive and efficient strategies for diagnosing onychomycosis.

[1]  E. Epstein,et al.  How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data. , 1998, Archives of dermatology.

[2]  R. Davies Mycological tests and onychomycosis , 1968, Journal of clinical pathology.

[3]  B. Elewski Diagnostic techniques for confirming onychomycosis. , 1996, Journal of the American Academy of Dermatology.

[4]  C. Daniel Tinea unguium. , 1986, Journal of the Mississippi State Medical Association.

[5]  C. R. Daniel The diagnosis of nail fungal infection. , 1991, Archives of dermatology.

[6]  H. N. Liu,et al.  KONCPA: a new method for diagnosing tinea unguium. , 1993, Dermatology.

[7]  B. Cho,et al.  Detection and differentiation of causative fungi of onychomycosis using PCR amplification and restriction enzyme analysis , 1998, International journal of dermatology.

[8]  W. Bergman,et al.  [Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine]. , 1994, Nederlands tijdschrift voor geneeskunde.

[9]  L. Gip,et al.  Differential Staining of Fungi in Clinical Specimens Using Fluorescent Whitening Agent (Blánkophor) * /Differentialfárbung von Pilzen im klinischen Material unter Anwendung eines fluoreszierenden Aufhellers (Blánkophor) , 1987, Mykosen.

[10]  J. Marley,et al.  Non‐dermatophytes in onychomycosis of the toenails , 1997, The British journal of dermatology.

[11]  R. Summerbell,et al.  Onychomycosis: an evaluation of three sampling methods. , 1998, Journal of the American Academy of Dermatology.

[12]  G. Achten,et al.  Onychomycoses in the laboratory. , 1978, Mykosen. Supplement.

[13]  A. Ackerman,et al.  Subtle clues to diagnosis from biopsies of nails. The value of nail biopsy for demonstrating fungi not demonstrable by microbiologic techniques. , 1980, The American Journal of dermatopathology.

[14]  J. Ring,et al.  Safety and efficacy of intermittent therapy with itraconazole in finger- and toenail onychomycosis: a multicentre trial. , 1998, Mycoses (Berlin).

[15]  L. Gip Differential Staining of Fungi in Clinical Specimens Using Fluorescent Whitening Agent , 1986 .

[16]  B. Elewski Clinical pearl: diagnosis of onychomycosis. , 1995, Journal of the American Academy of Dermatology.

[17]  R. Scher Onychomycosis: therapeutic update. , 1999, Journal of the American Academy of Dermatology.

[18]  P. Corcuff,et al.  [Microscopic diagnosis of onychomycoses]. , 1994, Annales de dermatologie et de venereologie.

[19]  M. Bigby,et al.  Evidence-based medicine in a nutshell. A guide to finding and using the best evidence in caring for patients. , 1998, Archives of dermatology.

[20]  B. Amichai,et al.  Adverse drug reactions of the new oral antifungal agents – terbinafine, fluconazole, and itraconazole , 1998, International journal of dermatology.

[21]  R. Auerbach,et al.  Histologic evaluation of nail clippings for diagnosing onychomycosis. , 1991, Archives of dermatology.

[22]  J. Ring,et al.  Safety and efficacy of intermittent therapy with itraconazole in finger‐ and toenail onychomycosis: a multicentre trial: Sicherheit und Wirksamkeit der intermittierenden Itraconazol‐Therapie von Onychomykosen der Finger und Zehen. Eine Multizenter‐Studie , 1998 .

[23]  J. Arrese,et al.  Present and potential diagnostic techniques in onychomycosis. , 1996, Journal of the American Academy of Dermatology.

[24]  B. Elewski,et al.  Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  R. Kirsner,et al.  Routine histologic examination for the diagnosis of onychomycosis: an evaluation of sensitivity and specificity. , 1998, Cutis.

[26]  R. Tubbs,et al.  Squamous cell carcinoma of the nail bed: a clinicopathological study of 12 cases , 1990, The British journal of dermatology.